Skip to main content
Divya Raghavan
( out of 50 reviews )

Divya Raghavan, MD

Languages spoken: English

Clinical Locations

Primary Location

Transplant Center

Transplant Center
50 N Medical Dr
Salt Lake City , UT 84132

University of Utah Hospital

Nephrology
50 N Medical Dr
Salt Lake City , UT 84132

Boise Area Specialty Clinic

3875 East Overland Road
Meridian , ID 83642

Farmington Health Center

Farmington Health Center Nephrology
165 N. University Ave.
Farmington , UT 84025
  • Divya Raghavan, MD is a Nephrologist and Clinical Associate Professor of Medicine, at the University of Utah School of Medicine.

    She completed her medical schooling at Kilpauk Medical College in India in 2011. She went on to finish her Internal Medicine Residency at the University of Illinois at Urbana-Champaign in 2015. She finished her General Nephrology fellowship at the University of Utah (2015-2017) followed by a Transplant Nephrology fellowship (2017-2018). She then joined the Division of Nephrology as a Transplant Nephrologist in 2018.

    She is the Program Director for the American Society of Transplant accredited Transplant Nephrology fellowship at the University of Utah. She is board certified in Internal Medicine and Nephrology.

    Her clinical interests include addressing barriers to increasing kidney transplantation as well as improving post kidney transplant outcomes.

    Board Certification

    American Board of Internal Medicine (Sub: Nephrology)
    American Board of Internal Medicine (Internal Medicine)

    Patient Rating

    4.9 /5
    ( out of 50 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    UH HOSPITALS AND CLINICS

    Top Notch. Intelligent and relatable. Explains things very well.

    UH HOSPITALS AND CLINICS

    Dr. Raghavan was great, and made me feel like I have a very good team to care for me when i get my transplant.

    UH HOSPITALS AND CLINICS

    She was concerned about all the medical issues I have had since our last meeting. She is looking into other ways to keep skin cancers in check and reduce other side effects of immuno suppressants.

    UH HOSPITALS AND CLINICS

    Happy

    UNIVERSITY HOSPITAL

    great

    UH HOSPITALS AND CLINICS

    Dr Raghaven was very thorough and involved me consistently in discussions of my current and future conditions. She listened to my concerns and offered solutions.

    UH HOSPITALS AND CLINICS

    telehealth video - some confusion in past notes.We went through them and the Dr did verifying and then was followed up with transplant - Kristen to make sure we where all on same page

    UNIVERSITY HOSPITAL

    She is a good Doctor , she listens to your questions and concerns. She tells you a great deal about what to expect.

    UNIVERSITY HOSPITAL

    She comes across as being knowledgeable on kidney transplants.

  • Divya Raghavan, MD is a Nephrologist and Clinical Associate Professor of Medicine, at the University of Utah School of Medicine.

    She completed her medical schooling at Kilpauk Medical College in India in 2011. She went on to finish her Internal Medicine Residency at the University of Illinois at Urbana-Champaign in 2015. She finished her General Nephrology fellowship at the University of Utah (2015-2017) followed by a Transplant Nephrology fellowship (2017-2018). She then joined the Division of Nephrology as a Transplant Nephrologist in 2018.

    She is the Program Director for the American Society of Transplant accredited Transplant Nephrology fellowship at the University of Utah. She is board certified in Internal Medicine and Nephrology.

    Her clinical interests include addressing barriers to increasing kidney transplantation as well as improving post kidney transplant outcomes.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Associate Professor (Clinical)
    Academic Divisions Nephrology & Hypertension
    Board Certification
    American Board of Internal Medicine (Sub: Nephrology)
    American Board of Internal Medicine (Internal Medicine)

    Education history

    Professional Medical Medicine - Kilpauk Medical College M.D.
    Internship Kilpauk Medical College Intern
    Residency Internal Medicine - University of Illinois College of Medicine at Urbana-Champaign Resident
    Residency University of Utah School of Medicine Visiting Resident
    Fellowship Nephrology - University of Utah School of Medicine Fellow
    Fellowship Transplant Nephrology - University of Utah School of Medicine Fellow

    Selected Publications

    Journal Article

    1. Yamauchi J, Raghavan D, Rofaiel G, Zimmerman M, Potluri VS, Baker T, Campsen J, Hall IE, Molnar M (2023). Therapeutic Donor Kidney Transplant Outcomes: Comparing Early US Experiences Using Optimal Matching. Transplantation direct, 9(12), e1554. (Read full publication)
    2. Sarwal A, Yamauchi J, Raghavan D, Shihab F, Fornadi K, Rofaiel G, Zimmerman M, Campsen J, Baker N, Akhila Ganireddy Y, Aviles-Ovalle L, Baker T, Hall IE, Molnar M (2023). Throwing stones: kidney stone incidence in living kidney donor candidates with increased metabolic risk. Renal failure, 45(1), 2226763. (Read full publication)
    3. Yamauchi J, Azhar A, Hall IE, Bhalla A, Potluri VS, Tanriover B, Gupta G, Imlay H, Truax C, Balaraman V, Raghavan D, Zimmerman M, Campsen J, Rofaiel G, Baker T, Molnar M (2023). Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2-Infected versus Noninfected Deceased Donors. Clinical journal of the American Society of Nephrology, 18(11), 1466-1475. (Read full publication)
    4. Yamauchi J, Raghavan D, Jweehan D, Oygen S, Marineci S, Hall IE, Molnar M (2024). Kidney Transplant Outcomes in Amyloidosis: US National Database Study. Transplantation, (Read full publication)
    5. Yamauchi J, Raghavan D, Imlay H, Jweehan D, Oygen S, Marineci S, Remport A, Hall IE, Molnar M (2024). Deceased Organ Donor HTLV Screening Practices Postelimination of Universal Screening in the United States. Transplantation direct, 10(10), e1707. (Read full publication)
    6. Yamauchi J, Raghavan D, Jweehan D, Oygen S, Marineci S, Hall IE, Molnar M (2024). Belatacept Versus Tacrolimus for Kidney Transplant Recipients of Deceased Donors With Acute Kidney Injury: US National Database Study. Transplantation, (Read full publication)
    7. Yamauchi J, Fornadi K, Raghavan D, Jweehan D, Oygen S, Marineci S, Buff M, Fenlon M, Selim M, Zimmerman M, Molnar M (2025). Development of BK polyomavirus-associated nephropathy risk prediction in kidney transplant recipients. Renal failure, 47(1), 2509785. (Read full publication)

    Editorial

    1. Raghavan D, Hall I (2021). Dialysis and Transplant Access: Kidney Capitalism at a Crossroads?. Clinical journal of the American Society of Nephrology, 16(6), 846-847. (Read full publication)
    2. Raghavan D, Tomacruz IDV, Hall I (2021). Deceased-Donor Kidneys: Is Past Performance an Indicator of Future Transplant Success?. Kidney international reports, 6(8), 2025-2027. (Read full publication)
    3. Yamauchi J, Hall IE, Raghavan (2024). Implantation Biopsy in Living-Donor Kidney Transplantation: Expectations, Utility, and Limitations. American journal of kidney diseases, (Read full publication)

    Letter

    1. Molnar MZ, Hall IE, Raghavan D, Shihab F, Imlay H, Hanson KE, Gomez CA, Campsen J, Kim R, Baker N, Rofaiel (2022). Kidney transplantation from SARS-CoV-2-positive deceased donor. American journal of transplantation, 22(4), 1280-1282. (Read full publication)